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Abstract. Green fluorescent protein (GFP) is a widely utilized 
molecular reporter of gene expression. However, its use in 
in vivo imaging has been restricted to transparent tissue 
mainly due to the tissue penetrance limitation of optical 
imaging. Magnetization transfer contrast (MTC) is a magnetic 
resonance imaging (MRI) methodology currently utilized to 
detect macromolecule changes such as decrease in myelin 
and increase in collagen content. MTC MRI imaging was 
performed to detect GFP in both in vitro cells and in an in vivo 
mouse model to determine if MTC imaging could be used to 
detect infection from Pseudomonas aeruginosa in murine 
tissues. It was demonstrated that the approach produces values 
that are protein specific and concentration dependent. This 
method provides a valuable, non‑invasive imaging tool to 
study the impact of novel antibacterial therapeutics on bacte-
rial proliferation and perhaps viability within the host system, 
and could potentially suggest the modulation of bacterial gene 
expression within the host when exposed to such compounds.
Introduction
Pseudomonas aeruginosa (P. aeruginosa) is one of the 
ESKAPE bacterial species that is particularly concerning, 
because they represent the largest group of nosocomial patho-
gens with growing incidences of antibiotic resistance (1,2). 
Plethora of studies are focused on eliminating or reducing 
P. aeruginosa infection by using novel molecules (3-5). 
The main problem is tracking the action of these molecules 
in vivo, with a non‑invasive method. Μagnetic resonance 
imaging (MRI) can be considered as a non‑invasive method 
for monitoring the course of the infection. An MRI approach 
using USPIO nanoparticles as molecules to label the macro-
phages that are present in the infected area has been reported 
and seems to open perspectives for testing novel anti‑infective 
compounds (6,7). Recently, the explosion in available fluo-
rescent proteins promises a wide variety of new tools for 
biological imaging, and in particular, for protein labeling 
and cell tracing (8). In the last decade, Green Fluorescent 
Protein (GFP) has been frequently used as a marker of gene 
expression, since it is non‑toxic for both animals and bacteria 
and thus useful for in vivo imaging (9). The introduction of 
GFP has revolutionized the field of cell biology and fluores-
cence microscopy (10). GFP is a naturally fluorescent protein, 
consisting of an 11‑strand β‑barrel wrapped around a central 
helix that is widely utilized as a fluorescent marker of gene 
expression (11). GFP is detected by optical spectroscopy 
through its fluorescent properties; the protein has a major 
excitation peak at 395 nm and in a normal solution gives emis-
sion peaking at 508 nm (11). In vivo GFP can be detected only 
if the tissue is transparent or if protein expression is close to 
tissue surface (12). Due to this limitation, most experiments 
utilizing this marker are focused on in vitro cell cultures, 
ex vivo histology slices, or transparent animal models (13,14).
GFP is extensively used in animal models, in transplan-
tation studies to determine the fate of transplanted cells, as 
well as for studying various biological processes. Published 
studies on in vivo MRI using GFP protein as a marker to label 
tumor cells for example melanoma cells (15) or stem cells (16) 
suggested that the labeling does not affect expression of other 
genes.
Recently, the magnetization transfer contrast (MTC) 
technique was used to detect GFP and was shown to produce 
protein‑specific values that seemed to be concentration 
dependent (17). MTC MRI has been utilized for detecting 
early macromolecular changes in the Tg2576 mouse model 
of Alzheimer's disease (18) for localizing the signal to noise 
ratio (SN) in vivo (19). MTC is an MRI technique able to detect 
changes in macromolecule concentration and composition (20). 
MTC is commonly used to track changes in myelination as a 
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way to grade multiple sclerosis lesions (21). Recently, MTC 
has also been utilized to detect macromolecular accumulation 
in a mouse model of early Alzheimer's disease (18).
The MTC technique uses the application of a radiofre-
quency pulse at a specific distance from the water resonance, 
known as the offset frequency. This radiofrequency pulse 
causes a loss of signal intensity proportional to macromo-
lecular concentration. When combined with a reference image, 
where the radiofrequency pulse is not applied, the percent 
of signal loss can be quantified in what is referred to as the 
magnetization transfer ratio (MTR). Specifically, MTC evalu-
ates changes in semisolid macromolecules (22).
This provides a flexible, non‑invasive in vivo molecular 
imaging system exclusively dependent on the concentration of 
the fluorescent reporter. Starting from these results the idea 
of this work was the possibility to follow the P. aeruginosa 
infection in vivo using the MTC MRI method and the GFP as 
a molecular marker.
Materials and methods
Bacterial strains and growth conditions. UCBPP‑PA14 (PA14) 
is a P. aeruginosa human clinical isolate (23). GFP‑tagged 
P. aeruginosa (PA‑GFP), (Fig. 1), GFP‑tagged E. coli 
(EC‑GFP) (both tagged with a stable plasmid expressing GFP) 
and non‑fluorescent P. aeruginosa (PA) cells were grown over-
night in 5 ml LB Lenox medium (Thermo Fisher Scientific, 
Inc., Waltham, MA, USA) at 37˚C under 200 rpm orbital 
shaking using glass tubes (VWR). The next day, bacteria were 
centrifuged, re‑suspended and diluted in phosphate‑buffered 
saline (PBS) to final concentrations of 5x106 and 5x105 cells/ml. 
The latter concentration is equivalent to the PA inoculum used 
in a murine burn and infection model. Then 0.2 ml microfuge 
tubes were filled to the maximum capacity with the diluted 
cultures (23). Fluorescence of the cells was confirmed by 
microscopy under the 1st section talking about the bacteria.
Phantom. One phantom was prepared to test and calibrate the 
experiments. Three microfuge tubes (capacity 0.2 ml) were 
filled to the maximum capacity with the diluted cultures of 
PA‑GFP, EC‑GFP and PA cells, respectively, and placed in 
a Falcon tube (2.7 cm inner diameter) filled with isotonic 
saline (NaCl) solution.
Animals. Six weeks old, CD‑1 mice were anesthetized and 
a leg burn injury of 5% total burn surface area (TBSA) was 
produced on the right thigh muscle. Briefly, animals were 
anesthetized with Xylazine (13 mg/kg, i.p.) and Ketamine 
(87 mg/kg, i.p.), thermally injured (5‑8% of body surface) on 
the shaved abdomen dermis, and intra‑dermally infected into 
the burn eschar. Mice were randomized into one experimental 
and control groups (N=6 per group). The experimental group 
consisted of burned mice infected with PA-GFP‑tagged 
PA14 P. aeruginosa strain containing no plasmid and 
the control group consisted of burned mice infected with 
wild‑type P. aeruginosa. Mice were infected as described in 
Rahme et al (23). An inoculum of 5x105 PA14 cells in 100 µl of 
PBS was injected intradermal into the burn eschar. The animal 
protocol was approved by the Massachusetts General Hospital 
Institutional Animal Care and Use Committee.
MRI experiments. The mice were imaged 12 h post‑burn and 
infection. During MRI, mice were kept anesthetized with a 
mixture of isoflurane and maintained at 37˚C.
We used a triple phantom in a 4.7 T horizontal bore magnet 
(20 cm bore diameter, Magnex Scientific, using a Bruker 
Avance console). The images were acquired in a 4.7 T horizontal 
magnet, 20 cm bore, equipped with gradient system capable of 
39 G/cm, Magnex Scientific, using a Bruker Avance console 
(Bruker BioSpin, Billerica, MA, USA) with a custom‑built 
volume coil of 3 cm inner diameter and 10 cm active length. The 
main magnetic field (B0) was shimmed and the RF filed (B1) 
was calibrated. We acquired a RARE sequence (also known 
as Fast Spin Echo, FSE) with magnetization transfer (24-26). 
The imaging pulse sequence comprised a pre‑saturation 
pulse at the designated offset frequency followed by a spin 
echo sequence with TE/TR=7.95/2,000 msec. Images were 
recorded with a 128x128 matrix, field of view, 3x3 cm; slice 
thickness, 3 mm; and average, 1. Pre‑saturation off‑resonance 
pulses ranged from ±0.05 to ±0.4 kHz.
Magnetization transfer ratios (MTR) in the form of 
MTR=(unsaturated‑saturated)/unsaturated were calculated 
from the signal intensities of regions of interest (ROI) using 
Paravision software (Bruker BioSpin).
Statistical analysis. Data are expressed as a mean ± standard 
deviation. Comparisons between groups were performed in 
each group using a two‑tailed t‑test (P‑value=0.05). Moreover 
we implemented the analysis with a One‑Way ANOVA anal-
ysis followed by Tukey's post hoc test using the Metaboanalyst 
online softaware (http://www.metaboanalyst.ca/).
Results
GFP cell model. We compared the MTC profiles of 
GFP‑tagged P. aeruginosa cells to those of the non‑fluores-
cent P. aeruginosa, GFP‑tagged and E. coli cells in culture. 
Cells were visualized in 0.2 ml tubes filled to capacity with 
5x105 cells/ml. The non‑fluorescent P. aeruginosa, was chosen 
as a non‑specific control to compare against GFP‑tagged 
bacteria, whereas E. coli was used as a specific control 
for the GFP to compare with both tagged and wild‑type 
P. aeruginosa. The goal was to find the frequency at which 
there was the largest difference between GFP‑tagged P. aeru-
ginosa and E. coli, and non‑fluorescent P. aeruginosa (Fig. 2). 
Samples were imaged first without and then with MTC. Nine 
MTC datasets were acquired from 0.05 to 0.4 kHz. The MTR 
was calculated from the images, and is shown in Fig. 3A. We 
found the largest difference between 0.2, 0.25 and 0.3 kHz 
(the peak difference was at 0.25 kHz) for EC‑GFP and for 
PA‑GFP with respect to PA (Fig. 3A). Pseudo‑colored pixel 
by pixel MTR calculations visually show a clear difference 
between the PA-GFP and PA phantoms (Fig. 3B); we found 
a statistically significant difference between PA and EC‑GFP 
(P<0.0001), and an even greater statistically significant differ-
ence between PA and PA‑GFP (P=0.00001). These simple 
t‑test analyst is confirmed by using a multiple comparison 
Tukey's analysis (One‑way ANOVA Analysis). The PA 
samples are strongly different from EC‑GFP and PA‑GFP 
and the data are statistically significant with P<0.001 and 
P<0.01 respectively.
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GFP mouse model. The comparison of the GFP‑tagged and 
non‑tagged live P. aeruginosa and E. coli cells using MTC 
MRI indicated that this method was sensitive enough to 
distinguish between GFP‑tagged and non‑tagged bacteria 
at cell concentrations relevant to those to be used in animal 
infection models. Accordingly, the MTC MRI profiles of mice 
infected with non‑tagged P. aeruginosa and mice infected 
with GFP‑tagged P. aeruginosa were compared to determine 
the frequency with the largest difference between them in the 
infected a burn area. Fig. 4 shows the in vivo MRI results from 
our experiments in mice, and the MTR maps demonstrated an 
enhancement in the GFP expressing infected animals. The two 
groups (GFP‑positive and GFP‑negative) were imaged first 
without and then with MTC. In addition, nine MTC datasets 
were acquired from 0.2 to 1.6 kHz. The control animal did 
not give any appreciable signal at this setting. The MTR was 
calculated from the images, and is shown in Fig. 5A. We found 
the largest difference between 0.8, 1 and 1.2 kHz, the peak 
difference being at 1 kHz, for the GFP‑positive with respect 
to the GFP‑negative mice. Fig. 5B shows the calculated MTR 
values; we found a statistically significant difference between 
GFP+ and GFP- with a P<0.0001.
The visual representation is more useful to assess the 
spatial distribution of signal changes compared to a single 
ROI analysis. The unsaturated images for a representative GFP 
expressing and control animal demonstrated different signal 
intensities. The MTR maps demonstrated an enhancement in 
the GFP expressing animals.
Discussion
MTC MRI methods have been used before to distinguish 
intrinsic macromolecule concentration changes. The main 
advantages of detecting GFP, an extrinsic protein marker, with 
MTC MRI compared to other MRI based reporters, such as 
USPIO are the non‑toxicity of the protein and the potential to 
detect the expression of a specific gene or product in vivo seri-
ally and non‑invasively. Our results confirm that we can detect 
GFP‑tagged live bacteria using MTC MRI both in vitro and 
in vivo.
Comparison of the GFP‑tagged  and non‑tagged live 
P. aeruginosa and E. coli cells using the MTC MRI meth-
odology indicated that this method was sensitive enough to 
distinguish between GFP‑tagged and non‑tagged bacteria and 
to successfully image in vivo GFP‑tagged P. aeruginosa in a 
non‑invasive manner. We observed a difference in the MRI 
MTR value between PA and PAGFP, which was statistically 
significant (P<0.0001).
Also, we report an in vivo study of GFP‑tagged MTC MRI 
in a burn mouse model infected with P. aeruginosa. The utility 
of this method is to visualize bacterial infections in vivo in real 
time, and to study the impact of novel therapeutics on bacterial 
proliferation and viability within the host system. The use of an 
extrinsic protein marker provides an added flexibility. The main 
advantages of detecting GFP with MTC MRI over other MRI 
based reporters includes that there are multiple GFP mouse 
lines available and it poses no toxicity to the host or the bacteria.
Our results confirm the hypothesis that we can detect 
GFP‑tagged live bacteria using MTC MRI.
The study reported here assessed detection of GFP through 
MTC MRI both in vitro and in vivo experiments. To provide 
optimal results and the best off‑set frequency we worked 
on the fine‑tuned and at the end we found that 1 kHz offset 
as the most robust offset frequency for the MTC detection 
of GFP and provided the difference between tagged and 
non‑tagged mice. Our results are similar to the data reported 
by Pérez‑Torres et al (17).
We were able to successfully use this methodology to image 
in vivo GFP‑tagged P. aeruginosa in a murine burn and infec-
tion model, showing the utility of MTC for tracking bacterial 
proliferation and gene expression in vivo in animal models in 
a non‑invasive manner. The significance of this method is that 
it can be used to visualize bacterial infections in vivo in real 
time without being restricted to the use of transparent tissue 
necessary for optical imaging. The innocuous nature of the 
technology allows for repeated imaging over time without 
damage to the host or the bacteria. Furthermore, this in vivo, 
MRI molecular imaging technique can detect varying levels 
of the GFP reporter, further establishing its utility for studying 
host‑bacterial interactions. In addition to the visualizing bacte-
rial infections and expression of GFP tagged gene, in vivo and 
in real time, this method could be suitable for assessing the 
efficacy of novel therapeutics on specific targets, and, bacterial 
proliferation and viability within the host system. 
Overall, this method provides a valuable, non‑invasive 
imaging tool to study the impact of novel antibacterial 
Figure 2. Pseudocolored pixel of EC‑GFP, PA‑GFP and PA at 0.25 kHz 
offset. GFP, green fluorescent protein; EC‑GFP, GFP‑tagged E. coli; 
PA‑GFP, GFP‑tagged Pseudomonas aeruginosa.
Figure 1. GFP‑tagged Pseudomonas aeruginosa cells viewed at x600 magni-
fication. GFP, green fluorescent protein.
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therapeutics on bacterial proliferation and perhaps viability 
within the host system, and could potentially give clues to the 
modulation of bacterial gene expression within the host when 
exposed to such compounds.
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